DE69633279D1 - Verfahren zur herstellung einer zusammensetzung enthaltend modifizierten tierlichen lungensurfactant - Google Patents

Verfahren zur herstellung einer zusammensetzung enthaltend modifizierten tierlichen lungensurfactant

Info

Publication number
DE69633279D1
DE69633279D1 DE69633279T DE69633279T DE69633279D1 DE 69633279 D1 DE69633279 D1 DE 69633279D1 DE 69633279 T DE69633279 T DE 69633279T DE 69633279 T DE69633279 T DE 69633279T DE 69633279 D1 DE69633279 D1 DE 69633279D1
Authority
DE
Germany
Prior art keywords
surfactant
lung surfactant
lung
phospholipid
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69633279T
Other languages
English (en)
Inventor
A Egan
A Holm
H Ferguson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ONY Inc
Original Assignee
ONY Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ONY Inc filed Critical ONY Inc
Application granted granted Critical
Publication of DE69633279D1 publication Critical patent/DE69633279D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
DE69633279T 1995-06-07 1996-06-05 Verfahren zur herstellung einer zusammensetzung enthaltend modifizierten tierlichen lungensurfactant Expired - Lifetime DE69633279D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/475,539 US6129934A (en) 1995-06-07 1995-06-07 Modification of animal lung surfactant for treating respiratory disease due to lung surfactant deficiency or dysfunction
PCT/US1996/008828 WO1996040177A1 (en) 1995-06-07 1996-06-05 Modified animal lung surfactant and its therapeutic use

Publications (1)

Publication Number Publication Date
DE69633279D1 true DE69633279D1 (de) 2004-10-07

Family

ID=23888024

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69633279T Expired - Lifetime DE69633279D1 (de) 1995-06-07 1996-06-05 Verfahren zur herstellung einer zusammensetzung enthaltend modifizierten tierlichen lungensurfactant

Country Status (7)

Country Link
US (1) US6129934A (de)
EP (1) EP0831862B1 (de)
AT (1) ATE274914T1 (de)
AU (1) AU5886896A (de)
CA (1) CA2221625A1 (de)
DE (1) DE69633279D1 (de)
WO (1) WO1996040177A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5958902A (en) * 1997-04-16 1999-09-28 Wisconsin Alumni Research Foundation Method and composition for treating sleep apnea
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
RU2232185C2 (ru) * 1998-07-30 2004-07-10 Колгейт-Палмолив Компани Микроэмульсия типа "вода в масле", для обеспечения косметических свойств основе смягчающей ткань композиции
WO2001019392A1 (en) * 1999-09-16 2001-03-22 Byk Gulden Lomberg Chemische Fabrik Gmbh Combination of c1-inh and lung surfactant for the treatment of respiratory disorders
US6156294A (en) 1999-11-28 2000-12-05 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
US6676930B2 (en) 1999-11-28 2004-01-13 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
US20040254112A1 (en) * 2000-04-12 2004-12-16 Dietrich Hafner Use of pulmonary surfactant for the early treatment of acute pulmonary diseases
JP2003530356A (ja) * 2000-04-12 2003-10-14 アルタナ ファルマ アクチエンゲゼルシャフト 急性肺疾患の予防又は早期治療のための肺表面活性物質の新規使用
PT1280520E (pt) 2000-05-10 2014-12-16 Novartis Ag Pós à base de fosfolípidos para administração de fármacos
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
RU2003108871A (ru) * 2000-09-01 2004-08-27 Маркус ЛАРССОН (SE) Композиции легочного сурфактанта с режимом динамического набухания
EP1458360B1 (de) 2001-12-19 2011-05-11 Novartis AG Pulmonale verabreichung von aminoglykosiden
EP1511391B1 (de) * 2002-05-23 2012-05-02 Ortho-Clinical Diagnostics, Inc. Einfang, konzentration und quantifizierung eines abnormalen prionproteins aus biologischen flüssigkeiten mittels tiefenfiltration
WO2006118966A2 (en) * 2005-05-03 2006-11-09 The Hospital For Sick Children Phospholipid formulations and uses thereof in lung disease detection and treatment
EP4366691A1 (de) 2021-07-05 2024-05-15 Chiesi Farmaceutici S.p.A. Verfahren zur herstellung eines lungensurfactants

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55160721A (en) * 1979-06-02 1980-12-13 Tokyo Tanabe Co Ltd Pulmonary surfactant ta-546, its preparation, and remedy for pulmonary hyaline membrane syndrome comprising it as active constituent
JPS5845299A (ja) * 1981-09-10 1983-03-16 東京田辺製薬株式会社 新規な表面活性物質、その製造法及びそれを含有する呼吸窮迫疾候群治療剤
JPS59164724A (ja) * 1983-03-10 1984-09-17 Tokyo Tanabe Co Ltd サ−フアクタント及びそれを含有する呼吸窮迫症候群治療剤
FR2586587B1 (fr) * 1985-08-30 1987-10-23 Adir Nouveaux surfactants artificiels, leur preparation et les compositions pharmaceutiques qui les contiennent.
US5013720A (en) * 1986-05-06 1991-05-07 Abbott Laboratories SAP-6-Val proteins and methods
IT1203873B (it) * 1987-04-08 1989-02-23 Chiesi Farma Spa Composizioni farmaceutiche che lo surfattante polmonare naturale, contengono. metodo di preparazione e
US5164369A (en) * 1988-01-06 1992-11-17 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
DE3921954A1 (de) * 1989-07-04 1991-01-17 Thomae Gmbh Dr K Niedrig-viskose, hochkonzentrierte surfactant-suspension
GB9021080D0 (en) * 1990-09-26 1990-11-07 Univ Western Ontario Lipid extract surfactant and method of producing same

Also Published As

Publication number Publication date
AU5886896A (en) 1996-12-30
WO1996040177A1 (en) 1996-12-19
EP0831862A1 (de) 1998-04-01
US6129934A (en) 2000-10-10
ATE274914T1 (de) 2004-09-15
CA2221625A1 (en) 1996-12-19
EP0831862B1 (de) 2004-09-01

Similar Documents

Publication Publication Date Title
DE69633279D1 (de) Verfahren zur herstellung einer zusammensetzung enthaltend modifizierten tierlichen lungensurfactant
CA2285203A1 (en) Compositions containing capsaicin or capsaicin analogues and a local anesthetic
BG105764A (en) Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant
ES2069380T3 (es) Composiciones para la higiene oral suaves y conservadoras del sabor.
ES2098207T1 (es) Producto para el cuidado de la piel y procedimiento de utilizacion.
ATE82127T1 (de) N-acetylglucosamin-zubereitungen zur buccalen anwendung.
NO893882L (no) Middel til forbedring av lipidmetabolisme og fremgangsmaate ved anvendelse derav.
ATE353919T1 (de) Verbesserte mischungen synthetischer lipide zur herstellung einer rekonstituierten oberflächenaktiven substanz
ATE333270T1 (de) Pharmazeutische zusammensetzung enthaltend magermilchpulver
UA26313A (uk) Засіб для замісhої терапії захворюваhь дихальhих шляхів, переважhо при сиhдромі задухи
Kobayashi et al. Exogenous porcine surfactant (Curosurf) is inactivated by monoclonal antibody to the surfactant‐associated hydrophobic protein SP‐B
Calura et al. Ultrastructural Observations on the Wound Healing of Free Gingival Connective Tissue Autografts With and Without Epithelium in Humans.
ATE192930T1 (de) Synthetische oberflächenaktive agentien auf der lunge
ATE184489T1 (de) Behandlung fehlender milchabsonderung beim menschen
ATE396706T1 (de) Verfahren zur herstellung von liposomalen wirkstoffformulierungen
EP1356814A4 (de) Pharmazeutische emulsionszubereitung
ES2092969A1 (es) Surfactante pulmonar natural de origen porcino.
DE60025806D1 (de) Verfahren zur herstellung von weinstein und natriumbicarbonat enthaltenden kosmetische zubereitungen
ES2192098T3 (es) Emulsion de aceite tipo en agua, con accion protectora frente a daños por peroxidacion en organos humanos, su fabricacion y utilizacion.
RU97102193A (ru) Способ получения стоматологических пластинок из комбинированного трансплантата
RU94016314A (ru) Способ пластики-задне-боковой стенки реконструированной гортани

Legal Events

Date Code Title Description
8332 No legal effect for de